Abstract: The present disclosure relates to a pharmaceutical composition for preventing, treating or ameliorating inflammatory bowel disease, containing, as an active ingredient, a specific solvent fraction obtained from Saururus chinensis; and a preparation method therefor.

Abstract: The specification relates to a composition for enhancing immunity, comprising a ginseng berry polysaccharide as an active ingredient. The composition can increase the expression of cytokines such as IL-6, IL-12, and TNF-? by using ingredients derived from natural products. In addition, the composition can exhibit excellent immunity enhancement effects because of the unique components and structure of a ginseng berry polysaccharide.

Abstract: The specification relates to a composition for enhancing immunity, comprising a ginseng berry polysaccharide as an active ingredient. The composition can increase the expression of cytokines such as IL-6, IL-12, and TNF-? by using ingredients derived from natural products. In addition, the composition can exhibit excellent immunity enhancement effects because of the unique components and structure of a ginseng berry polysaccharide.

Abstract: The present invention relates to an immuno-enhancing composition including a corn-derived polysaccharide. The immuno-enhancing composition may be a food composition, a feed composition, or a pharmaceutical composition.

Abstract: The present invention relates to an immuno-enhancing composition including a corn-derived polysaccharide. The immuno-enhancing composition may be a food composition, a feed composition, or a pharmaceutical composition.

Abstract: A persimmon leaf-derived polysaccharide fraction consisting of 60-80 wt % of neutral sugar and 18-39 wt % of uronic acid, and 0.5-10 wt % of 3-deoxy-D-manno-2-octulosonic acid (KDO) analogs, the wt % based on the total weight of the polysaccharide fraction.

Abstract: A persimmon leaf-derived polysaccharide fraction, a preparation method thereof, and use thereof, the persimmon leaf-derived polysaccharide fraction including, based on the total weight of the polysaccharide fraction, 70-90 wt % of neutral sugar and 10-30 wt % of uronic acid.

Abstract: A persimmon leaf-derived polysaccharide fraction consisting of 60-80 wt % of neutral sugar and 18-39 wt % of uronic acid, and 0.5-10 wt % of 3-deoxy-D-manno-2-octulosonic acid (KDO) analogs, the wt % based on the total weight of the polysaccharide fraction.

Abstract: Disclosed are an immune-boosting food composition containing a green tea hydrolysate as an active component, and a method for preparing the same.

Abstract: A persimmon leaf-derived polysaccharide fraction, a preparation method thereof, and use thereof, the persimmon leaf-derived polysaccharide fraction including, based on the total weight of the polysaccharide fraction, 70-90 wt % of neutral sugar and 10-30 wt % of uronic acid.

Abstract: Disclosed are an immune-boosting food composition containing a green tea hydrolysate as an active component, and a method for preparing the same.

Abstract: Disclosed are alphavirus-based expression vectors expressing env, gag, pro, and/or pol genes of HIV-1, their transcripts, and transformed host cells. The present invention describes the expression of the Gag, Env, Pol, and/or Pro Proteins using the above expression vectors, and HIV-like particles (HIVLPs) composed of the above recombinant proteins. The virus-like particles (VLPs) of the present invention, as the mature and infective particles, are very useful as an antigen for a diagnostic kit for HIV infection as well as for a vaccine composition for prevention of HIV infection.

Abstract: Disclosed are alphavirus-based expression vectors expressing env,gag,pro, and/or pol genes of HIV-1, their transcripts, and transformed host cells. The present invention describes the expression of the Gag,Env,Pol and/or Pro Proteins using the above expression vectors, and HIV-like particles(HTVLPs) composed of the above recombinant proteins. The virus-like particles (VLPs) of the present invention, as the matuer and infective particles, are very useful as an antigen for a diagnostic kit for HIV infection as well as for vaccine composition for prevention of HIV infection.

Abstract: The present invention relates to a method of bleaching blood samples, a diagnostic method and a diagnostic kit using whole blood samples. More particularly, this invention relates to the method of bleaching blood samples employing oxidant such as hydrogen peroxide, hypochlorite, permanganate, bichromate and nitrite, the diagnosis method for detecting antigen or antibody in blood samples and the diagnostic kit employing the above bleaching method and the conventional immunochromatographic assay.

Abstract: The present invention relates to a method of bleaching blood samples, a diagnostic method and a diagnostic kit using whole blood samples. More particularly, this invention relates to the method of bleaching blood samples employing oxidant such as hydrogen peroxide, hypochlorite, permanganate, bichromate and nitrite, the diagnosis method for detecting antigen or antibody in blood samples and the diagnostic kit employing the above bleaching method and the conventional immunochromatographic assay.